Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys

This publication has 33 references indexed in Scilit:

• Quantification of Amphetamine-Induced Changes in [¹¹C]Raclopride Binding with Continuous Infusion
  Journal of Cerebral Blood Flow & Metabolism, 1997
• Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1994
• Phencyclidine and the midbrain dopamine system: Electrophysiology and behavior
  Neurotoxicology and Teratology, 1994
• Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
  Proceedings of the National Academy of Sciences, 1993
• Striatal binding of the PET ligand ¹¹C‐raclopride is altered by drugs that modify synaptic dopamine levels
  Synapse, 1993
• GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography
  Journal of Neuroscience, 1992
• Amphetamine induced decreases in (¹⁸F)‐N‐methylspiroperidol binding in the baboon brain using positron emission tomography (PET)
  Synapse, 1991
• Positron emission tomography (PET) studies of dopaminergic/cholinergic interaction in the baboon brain
  Synapse, 1990
• SEROTONIN AND DOPAMINE METABOLITES IN BRAIN REGIONS AND CEREBROSPINAL FLUID OF A PRIMATE SPECIES: EFFECTS OF KETAMINE AND FLUPHENAZINE
  Journal of Neurochemistry, 1979
• Immunohistochemical localization of choline acetyltransferase containing neostriatal neurons and their relationship with dopaminergic synapses
  Brain Research, 1976